PJC
PFE icon

Phillip James Consulting’s Pfizer PFE Stock Holding History

Phillip James Consulting’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$14K Hold
581
– – 0.01% 151
2026
Q1 		$16K Buy
581
+34
+6% +$905 0.01% 165
2025
Q4 		$14K Buy
+547
New +$13.8K 0.25% 50

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Phillip James Consulting's PFE Position: Q2 2026 in Review

Phillip James Consulting held its Pfizer (PFE) position steady in Q2 2026 at 581 shares worth $14K. The position accounts for 0.01% of the portfolio, ranked #151.

Phillip James Consulting first reported a position in PFE in Q4 2025 and has held it in 3 quarters since. The position peaked at $16K in Q1 2026. 2,818 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Phillip James Consulting held 581 shares of Pfizer worth $14K as of Q2 2026.
  • Phillip James Consulting left its Pfizer share count unchanged in Q2 2026.
  • Pfizer made up 0.01% of Phillip James Consulting's portfolio in Q2 2026, its #151 holding.
  • Phillip James Consulting first reported a position in Pfizer in Q4 2025 and has held it in 3 quarters since.
  • Phillip James Consulting's Pfizer position peaked at $16K in Q1 2026.
  • 2,818 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Phillip James Consulting's 13F filing for Q2 2026, filed 28 Jul 2026.